Bringing the fundamentals into focus…
Back to Enovis Corporation
How Enovis Corporation stacks up
ENOV · against 465 other Healthcare companies of similar size
Valuation
70/ 100
Above the middle of the pack.
Ranked #160 of 466 · scores higher than 65% of peers
Bars: peers in each 10-point band of the valuation score50 peers with a valuation score of 70–79, including ENOV · Click a bar to see the companies
Why valuation scores 70?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -92.1% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 81% of peers. Free cash flow yield: 5.3% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 90% of peers. EBITDA yield: 14.8% vs peer median 4.0%
Metric by metric
Position: dot = ENOV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 457 reported | -92.1% | 1.5% | 0% | 30% | |
| EBITDA yieldHigher is better · 469 reported | 14.8% | 4.3% | 91% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | 5.3% | -1.6% | 77% | 20% | |
| Book yieldHigher is better · 461 reported | 122.6% | 40.8% | 95% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ENOV| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 154 | 157.8B INR (≈$1.9B) | 72 | 64 | |
| 158 | 2.4B SGD (≈$1.8B) | 71 | 79 | |
| 158 | 1.3B USD | 71 | 29 | |
| 160 | 5.8B CNY (≈$807M) | 70 | 67 | |
| 160 | 1.2B USD | 70 | 46 | |
| 160 | 168.6B INR (≈$2.0B) | 70 | 63 | |
| 160 | 174.8B INR (≈$2.1B) | 70 | 73 | |
| 160 | 2.3B USD | 70 | 67 | |
| 165 | 5.1B CNY (≈$719M) | 69 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score